You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TIL

Showing 1 - 25 of 515
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors, Adult Trial in Xuzhou (TIL injection)

Recruiting
  • Solid Tumors, Adult
  • TIL injection
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital Of Xuzhou Medical University
Oct 12, 2023

NSCLC Trial in Zhengzhou (L-TIL, Tislelizumab, Docetaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • L-TIL, Tislelizumab, Docetaxel
  • Zhengzhou, Henan, China
    No.127 Dongming Road
May 17, 2023

Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)

Recruiting
  • Tumor Infiltrating Lymphocytes
  • +4 more
  • GC101 TIL
  • Beijing, China
    Beijing Cancer Hospital
Nov 7, 2023

Advanced Gynecologic Tumors, Signal Switch Receptor Modified TIL, Treatment Side Effects Trial in Shanghai (Signal Switch

Recruiting
  • Advanced Gynecologic Tumors
  • +3 more
  • Signal Switch Receptor Modified TIL
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Dec 20, 2022

Breast Cancer, Treatment Side Effects, Advanced Breast Cancer Trial in Shanghai (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Breast Cancer
  • +3 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Tumor-infiltrating Lymphocytes (TIL)
  • +5 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Glioma Trial in Suzhou (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Glioma
  • Tumor Infiltrating Lymphocytes (TIL)
  • Suzhou, Jiangsu, China
    The Second Affiliated Hospital of Soochow University
Dec 19, 2022

Metastatic Non Small Cell Lung Cancer Trial in Raleigh (C-TIL051)

Not yet recruiting
  • Metastatic Non Small Cell Lung Cancer
  • C-TIL051
  • Raleigh, North Carolina
    Duke Cancer Institute
Jan 6, 2023

Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

Recruiting
  • Urothelial Carcinoma
  • Non-Invasive Bladder Urothelial Carcinoma
  • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
  • Tampa, Florida
    Moffitt Cancer Center
Mar 2, 2023

Breast Cancer, Colorectal Cancer, Uveal Melanoma Trial in Orlando, Pittsburgh (TBio-4101, Pembrolizumab)

Recruiting
  • Breast Cancer
  • +2 more
  • Orlando, Florida
  • +1 more
Feb 1, 2023

PDO/PDO-TIL/PDOTS for Drug Screen

Recruiting
  • Liver Cancer
  • Metastatic Liver Cancer
  • Drug screen with PDO/PDO-TIL/PDOTS
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Jun 13, 2023

Solid Tumor Trial in Shanghai (BEN101)

Not yet recruiting
  • Solid Tumor
  • BEN101
  • Shanghai, Shanghai, China
  • +1 more
Apr 14, 2023

Advanced Gynecologic Tumors, TIL Engineered With Membrane-Binding Cytokine, Treatment Side Effects Trial in Shanghai (Membrane

Recruiting
  • Advanced Gynecologic Tumors
  • +3 more
  • Membrane Bound Cytokine Modified TIL
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Jul 25, 2022

Advanced Pancreatic Cancer Trial in Nanjing (Adoptive TIL-TCM transfer therapy)

Recruiting
  • Advanced Pancreatic Cancer
  • Adoptive TIL-TCM transfer therapy
  • Nanjing, Jiangsu, China
    Jinling Hospital
Jun 29, 2022

Advanced Melanoma, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

Recruiting
  • Advanced Melanoma
  • +3 more
  • Tumor Infiltrating Lymphocyte
  • Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

Tumor Infiltrating Lymphocytes, Safety, Advanced Solid Tumor Trial in Beijing (TIL therapy)

Recruiting
  • Tumor Infiltrating Lymphocytes
  • +5 more
  • TIL therapy
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 19, 2022

Solid Tumor Trial (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide Capsules)

Not yet recruiting
  • Solid Tumor
  • Tumor Infiltrating Lymphocytes
  • +3 more
  • (no location specified)
Dec 11, 2022

HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

Recruiting
  • HNSCC
  • +5 more
  • DP CD8 TIL
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jun 5, 2023

Advanced Solid Tumors Trial in Shanghai (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Advanced Solid Tumors
  • Tumor Infiltrating Lymphocytes (TIL)
  • Shanghai, China
    Tongren Hospital Shanghai Jiao Tong University School Of Medicin
Jul 25, 2022

Advanced Liver Cancers, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

Recruiting
  • Advanced Liver Cancers
  • +4 more
  • Tumor Infiltrating Lymphocyte
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

Metastatic Melanoma Trial in New Haven (Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab)

Terminated
  • Metastatic Melanoma
  • Tumor Infiltrating Lymphocytes
  • Nivolumab and Ipilimumab
  • New Haven, Connecticut
    Yale New Haven Hospital
Jul 20, 2022

Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes

Recruiting
  • Toxicity, Drug
  • +2 more
  • Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
  • Leiden, Netherlands
    Leiden University Medical Center
Aug 16, 2022

pCR After Neoadjuvant Therapy in Breast Cancer Patients

Recruiting
  • Breast Cancer
  • TIL assessment in pre-existing histopathological specimens
  • Cairo, Egypt
    Faculty of Medicine, Ain Shams University
Jul 25, 2022

Advanced Breast Cancer, Advanced Lung Cancer Trial (Tumor-infiltrating lymphocytes, IL-2)

Not yet recruiting
  • Advanced Breast Cancer
  • Advanced Lung Cancer
  • Tumor-infiltrating lymphocytes
  • IL-2
  • (no location specified)
Oct 26, 2023

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023